HUMAN GENOME SCIENCES INC Depreciation and Amortization Expense
HUMAN GENOME SCIENCES INC reported Depreciation and Amortization Expense of $12.24 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-06-30 was $6.08M, a 12.61% increase year-over-year.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-03-31 was $6.16M, a 15.04% increase year-over-year.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for the quarter ending 2011-12-31 was $5.60M, a 5.07% increase year-over-year.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for the quarter ending 2011-09-30 was $5.33M, a 0.22% decline year-over-year.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for fiscal 2011 was $21.69M, a 1.79% increase from fiscal 2010.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for fiscal 2010 was $21.30M, a 0.24% increase from fiscal 2009.
- HUMAN GENOME SCIENCES INC depreciation, depletion and amortization, nonproduction for fiscal 2009 was $21.25M.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|
| 2012-06-30 | $6.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $12.24M 10-Q · filed 2012-07-26 | $17.84M derived: sum of 3 quarters · filed 2012-07-26 | $23.17M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $6.16M 10-Q · filed 2012-04-26 | $11.76M derived: sum of 2 quarters · filed 2012-04-26 | $17.09M derived: sum of 3 quarters · filed 2012-04-26 | $22.49M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $10.93M derived: sum of 2 quarters · filed 2012-02-28 | $16.33M derived: sum of 3 quarters · filed 2012-07-26 | $21.69M 10-K · filed 2012-02-28 |
| 2011-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $10.73M derived: sum of 2 quarters · filed 2012-07-26 | $16.09M 10-Q · filed 2011-10-28 | $21.42M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $5.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $10.75M 10-Q · filed 2012-07-26 | $16.08M derived: sum of 3 quarters · filed 2012-07-26 | $21.43M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $5.35M 10-Q · filed 2012-04-26 | $10.68M derived: sum of 2 quarters · filed 2012-04-26 | $16.03M derived: sum of 3 quarters · filed 2012-04-26 | $21.40M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $10.67M derived: sum of 2 quarters · filed 2012-02-28 | $16.05M derived: sum of 3 quarters · filed 2012-02-28 | $21.30M 10-K · filed 2012-02-28 |
| 2010-09-30 | $5.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $10.71M derived: sum of 2 quarters · filed 2011-10-28 | $15.97M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $10.63M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $5.26M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $21.25M 10-K · filed 2012-02-28 |